50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
NASDAQ:ITRM

Iterum Therapeutics - ITRM News Today

$1.79
+0.14 (+8.48%)
(As of 09/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.60
$1.84
50-Day Range
$1.59
$43.50
52-Week Range
$1.58
$11.25
Volume
48,504 shs
Average Volume
157,480 shs
Market Capitalization
$21.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Iterum Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITRM and its competitors with MarketBeat's FREE daily newsletter.



ITRM Media Mentions By Week

ITRM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ITRM
News Sentiment

1.11

0.77

Average
Medical
News Sentiment

ITRM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ITRM Articles
This Week

5

0

ITRM Articles
Average Week

SourceHeadline
MarketBeat logoIterum Therapeutics plc (NASDAQ:ITRM) Director Sells $26,550.00 in Stock
americanbankingnews.com - September 22 at 6:50 AM
MarketBeat logoIterum Therapeutics plc (NASDAQ:ITRM) Director Brenton Karl Ahrens Sells 15,000 Shares
americanbankingnews.com - September 21 at 6:48 AM
finance.yahoo.com logoIterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
finance.yahoo.com - September 19 at 9:57 AM
finance.yahoo.com logoIterum Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 7 at 11:31 AM
finance.yahoo.com logoIterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
finance.yahoo.com - September 1 at 4:34 PM
finance.yahoo.com logoIterum Therapeutics (NASDAQ:ITRM) Has Debt But No Earnings; Should You Worry?
finance.yahoo.com - August 17 at 10:46 AM
finanznachrichten.de logoIterum Therapeutics plc: Iterum Therapeutics Announces Date of 1-for-15 Reverse Share Split
finanznachrichten.de - August 17 at 5:46 AM
finance.yahoo.com logoIterum Therapeutics Announces Date of 1-for-15 Reverse Share Split
finance.yahoo.com - August 17 at 12:46 AM
finance.yahoo.com logoIterum Therapeutics Reports Second Quarter 2022 Financial Results
finance.yahoo.com - August 12 at 7:29 AM
finance.yahoo.com logoIterum Therapeutics Shares Are Surging - Read Why
finance.yahoo.com - July 11 at 10:41 PM
finance.yahoo.com logoIterum Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA
finance.yahoo.com - July 11 at 9:10 AM
finance.yahoo.com logoIterum Therapeutics Reports First Quarter 2022 Financial Results
finance.yahoo.com - May 13 at 6:47 PM
apnews.com logoIterum Therapeutics Presented Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases
apnews.com - April 25 at 6:28 PM
finance.yahoo.com logoIterum Expects To Start Additional Sulopenem Trial In Urinary Tract Infections In 2H22
finance.yahoo.com - March 28 at 4:28 PM
seekingalpha.com logoIterum Therapeutics GAAP EPS of -$0.02 beats by $0.02
seekingalpha.com - March 28 at 11:28 AM
finance.yahoo.com logoIterum Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
finance.yahoo.com - March 28 at 11:28 AM
finance.yahoo.com logoIterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2021 Financial Results on March 28, 2022
finance.yahoo.com - March 21 at 10:08 AM
finance.yahoo.com logoIterum Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
finance.yahoo.com - March 10 at 11:28 AM
nasdaq.com logoIterum Therapeutics plc Ordinary Share (ITRM)
nasdaq.com - February 8 at 3:16 AM
finance.yahoo.com logoIterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - December 14 at 5:32 PM
finance.yahoo.com logoIs Iterum Therapeutics (NASDAQ:ITRM) Weighed On By Its Debt Load?
finance.yahoo.com - December 14 at 12:32 PM
finance.yahoo.com logoIterum Therapeutics Appoints Sailaja Puttagunta, MD as Chief Medical Officer
finance.yahoo.com - December 13 at 10:49 AM
finance.yahoo.com logoIterum Therapeutics PLC (ITRM) Could Find Support Soon, Here's Why You Should Buy the Stock Now
finance.yahoo.com - November 22 at 2:16 PM
nasdaq.com logoIs Iterum Therapeutics (NASDAQ:ITRM) A Risky Investment?
nasdaq.com - November 12 at 9:46 AM
finance.yahoo.com logoIterum Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - November 12 at 9:46 AM
finance.yahoo.com logoIterum Therapeutics to Provide Business Update and Report Third Quarter 2021 Financial Results on November 12, 2021
finance.yahoo.com - November 5 at 10:25 AM
finance.yahoo.com logoFINAL DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - October 4 at 4:07 PM
finance.yahoo.com logoITRM LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Iterum Therapeutics Plc
finance.yahoo.com - October 4 at 4:07 PM
finance.yahoo.com logoDEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - October 4 at 11:07 AM
finance.yahoo.com logoITRM Final Deadline Today: Rosen, National Trial Lawyers, Encourages Iterum Therapeutics plc Investors with Losses to Secure Counsel Before Important October 4 Deadline in Securities Class Action - ITRM
finance.yahoo.com - October 4 at 11:07 AM
finance.yahoo.com logoCLASS ACTION UPDATE for ZY, ITRM and SAM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - October 4 at 11:07 AM
finance.yahoo.com logoLast Few Hours for Investors to Actively Participate in Iterum Therapeutics plc (ITRM) Class Action - Bronstein, Gewirtz & Grossman, LLC
finance.yahoo.com - October 4 at 11:07 AM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ITRM, SESN and WDH
finance.yahoo.com - October 4 at 11:07 AM
finance.yahoo.com logoDEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Iterum Therapeutics plc and Encourages Investors to Contact the Firm
finance.yahoo.com - October 1 at 9:00 PM
finance.yahoo.com logoMonday Deadline for Investors to Actively Participate in Iterum Therapeutics plc (ITRM) Class Action - Bronstein, Gewirtz & Grossman, LLC
finance.yahoo.com - October 1 at 3:59 PM
finance.yahoo.com logoThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of ITRM, ATIP and SESN
finance.yahoo.com - October 1 at 3:59 PM
markets.businessinsider.com logoPre-market Movers: PROG, ITRM, PALT, SDPI, IRNT…
markets.businessinsider.com - October 1 at 10:07 AM
finance.yahoo.com logoITRM FINAL NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Iterum Therapeutics plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
finance.yahoo.com - October 1 at 4:12 AM
finance.yahoo.com logoITRM Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Iterum Therapeutics plc Shareholders of Class Action and Lead Plaintiff Deadline: October 4, 2021
finance.yahoo.com - September 30 at 1:11 PM
finance.yahoo.com logoThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of ITRM, SLQT and SAM
finance.yahoo.com - September 30 at 1:11 PM
benzinga.com logoThinking about buying stock in Farmmi, Iterum Therapeutics, EQT Corp, SoFi Technologies, or Regis Corp?
benzinga.com - September 30 at 2:50 AM
finance.yahoo.com logoITRM MONDAY DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action Lawsuit
finance.yahoo.com - September 29 at 9:49 PM
finance.yahoo.com logoCLASS ACTION UPDATE for ZY, ITRM and HYRE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
finance.yahoo.com - September 28 at 10:11 AM
finance.yahoo.com logoIterum Therapeutics to Present Data at IDWeek 2021
finance.yahoo.com - September 28 at 10:11 AM
finance.yahoo.com logoMONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - September 28 at 10:11 AM
finance.yahoo.com logoIterum Therapeutics Provides Update from FDA Type A Meeting Regarding Oral Sulopenem
finance.yahoo.com - September 28 at 10:11 AM
finance.yahoo.com logoLAWSUITS FILED AGAINST ATVI, ITRM and KPLT - Jakubowitz Law Pursues Shareholders Claims
finance.yahoo.com - September 28 at 10:11 AM
finance.yahoo.com logoITRM DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Iterum Therapeutics plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
finance.yahoo.com - September 27 at 1:33 PM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AHCO, ITRM and SESN
finance.yahoo.com - September 27 at 1:33 PM
finance.yahoo.com logoITERUM THERAPEUTICS PLC (NASDAQ: ITRM) OCTOBER 4, 2021 INVESTOR FILING DEADLINE:
finance.yahoo.com - September 27 at 1:33 PM
Get Iterum Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITRM and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ITRM) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.